CLINICAL_TRIALS
trial_result
· 2024-11-07
Clinical Trial Update: A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder [Phase 2]
Summary
A Phase 2 trial evaluated BI 1358894 for 8 weeks in adults with post-traumatic stress disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-11-07